Primary myelofibrosis: Older age and high JAK2 V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease-Reference-Cited by-同舟云学术

Primary myelofibrosis: Older age and high JAK2 V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease

Published:2017-09 Issue: Volume:60 Page:18-23
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Barosi Giovanni,Massa Margherita,Campanelli Rita,Fois Gabriela,Catarsi Paolo,Viarengo Gianluca,Villani Laura,Poletto Valentina,Bosoni Tiziana,Magrini Umberto,Gale Robert P.,Rosti Vittorio

Funder

Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference48 articles.

1. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management;Tefferi;Am. J. Hematol.,2016

2. A primer on genomic and epigenomic alterations in the myeloproliferative neoplasms;Rampal;Best Pract. Res. Clin. Haematol.,2014

3. Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis;Rampal;Blood.,2014

4. Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα;Wang;PLoS One,2015

5. Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis;Massa;Blood,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study;Oncohematology;2024-09-01

2. Cytogenetics and genomics in CML and other myeloproliferative neoplasms;Best Practice & Research Clinical Haematology;2024-06

3. Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements;Cancers;2024-01-25

4. Review of the Predictive Value of Biomarkers in Sepsis Mortality;Emergency Medicine International;2024-01

5. BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing;Frontiers in Genetics;2023-09-08